RBC Capital Markets adjusted its stance on Intra-Cellular Therapies shares, downgrading the biopharmaceutical company from Outperform to Sector Perform. The firm, however, raised its price target on ...

Infinity Natural Resources, Inc. (“Infinity”) announced today the launch of its initial public offering of 13,250,000 shares of Class A common stock, ...

RBC Capital Markets analysts raised the price target for Webster Financial Corporation, traded on the New York Stock Exchange ...

In a report released today, Luca Issi from RBC Capital maintained a Buy rating on Alnylam Pharma (ALNY – Research Report), with a price target ...

Following almost ten years at ING bank, market structure expert Stephane Malrait joined Etrading Software as chair of its ...

In a report released on January 16, Gerard Cassidy from RBC Capital maintained a Buy rating on PNC Financial (PNC – Research Report), with a ...

Critchley’s departure coincided with that of Dave Thomas, who retired as CEO of RBC Capital Markets Europe at the end of the ...

Ballet Hispánico will present Gustavo Ramírez Sansano's masterwork CARMEN.maquia at New York City Center from May 29-June 1, ...

NEW YORK, January 02, 2025--(BUSINESS WIRE ... MUFG Securities Americas Inc., Mizuho Securities USA LLC, RBC Capital Markets, LLC and Truist Securities, Inc. are acting as joint book-running ...